Elevated Liver Enzymes in HIV Monoinfected Patients on HIV Therapy: What Are the Implications?(Leading Article) (Human Immunodeficiency Virus) (Report)
Journal of HIV Therapy 2009, March, 14, 1
Journal of HIV Therapy
This book can be downloaded and read in iBooks on your Mac or iOS device.
Liver enzyme elevations (LEE) in patients infected with the human immunodeficiency virus (HIV) are common . In some cases they are transient and of minor clinical interest, in other cases they are caused by alcohol consumption or by co-infection with other viral diseases, such as hepatitis B virus (HBV) infection or hepatitis C virus (HCV) infection. However, in an important number of patients the origin of liver enzyme elevation is not explained by an underlying liver disease or toxin and may occur either due to antiretroviral drug toxicity or the HIV infection itself. As HIV patients benefit from their antiretroviral treatment (ART) and consequent immunological stabilisation [2,3], continuous long-term treatment is inevitable. Although ART clearly has prolonged survival benefit for patients, it has led to a number of unexpected drug-induced toxicities: lipodystrophy, insulin resistance, dyslipidaemia and direct hepatotoxic injury . Transaminase elevations have been described during antiretroviral treatment by various mechanisms, leading to morbidity, mortality and drug discontinuation . Consequently, prevention and management of antiretroviral drug-related liver injury have emerged as major issues among HIV-infected patients in the era of combination ART .
- Category: Health & Fitness
- Published: Mar 01, 2009
- Publisher: Mediscript Ltd.
- Seller: The Gale Group, Inc.
- Print Length: 16 Pages
- Language: English
More by Journal of HIV Therapy
- Implications of the SILCAAT and ESPRIT Trials and the Future for HIV Immunotherapy (Leading Article) (Human Immunodeficiency Virus) (Enhanced Suppression of the Platelet Iib/Iiia Receptor with Integrilin Therapy) (Study of Interleukin-2 in People with Low CD4+ T Cell Counts on Active Anti-Human Immunodeficiency Virus Therapy) (Report)